“The Protective Effect of Dapagliflozin Against Contrast-Induced Nephropathy After Percutaneous Coronary Catheterization in Patients Moderate to High-Risk for CIN”. Vascular and Endovascular Review, vol. 8, no. 5s, Nov. 2025, pp. 154-61, https://doi.org/10.64149/J.Ver.8.5s.154-161.